KRINGLE PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 611 JPY | -4.68% |
|
+6.45% | -18.75% |
Chart calendar Kringle Pharma, Inc.
ded0880057029f0b7f.URP71d0Yt1LMIiPMJyoCwWQtS2Dc9y0PG7ewuF2Ik9c.C2OOn-p_0j6EF3m1FGRBkRJkEyW6gEdifNja7D_q-p8oa5i7sUiaPIJ1ag~6b6ddfee3c29d8e5609978c84fe3f21a
Upcoming events on Kringle Pharma, Inc.
Past events on Kringle Pharma, Inc.
| 13/05/2024 | Q2 2024 Earnings Release |
| 09/02/2024 | Q1 2024 Earnings Release |
| 13/11/2023 | Q4 2023 Earnings Release |
| 14/08/2023 | Q3 2023 Earnings Release |
| 15/05/2023 | Q2 2023 Earnings Release |
| 10/02/2023 | Q1 2023 Earnings Release |
| 14/11/2022 | FY 2022 Earnings Release |
| 12/08/2022 | Q3 2022 Earnings Release |
| 13/05/2022 | Interim 2022 Earnings Release |
| 14/02/2022 | Q1 2022 Earnings Release |
| 12/11/2021 | FY 2021 Earnings Release |
| 13/08/2021 | Q3 2021 Earnings Release |
| 14/05/2021 | Interim 2021 Earnings Release |
| 12/02/2021 | Q1 2021 Earnings Release |
Annual results
| Fiscal Period | September | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 468 | 289 | 391 | 69,0 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million JPY | Released Forecast Spread | -171 | -357 | -426 | -888 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -116 | -299 | -330 | -852 |
|
Net income Million JPY | Released Forecast Spread | -117 | -301 | -331 | -854 |
|
EPS JPY | Released Forecast Spread | -2 134 | -72,5 | -68,3 | -158 |
| Announcement Date | 28/12/20 | 12/11/21 | 14/11/22 | 13/11/23 |
Quarterly results
| Fiscal Period | September | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 117 | 27,0 | 85,0 | 17,0 | 34,0 | 17,0 | 18,0 | 43,0 |
|
EBIT Million JPY | Released Forecast Spread | -169 | -310 | -73,0 | -157 | -314 | -306 | -168 | -366 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -191 | -318 | 13,0 | -157 | -314 | -263 | -169 | -365 |
|
Net income Million JPY | Released Forecast Spread | -192 | -319 | 13,0 | -157 | -315 | -263 | -169 | -366 |
|
EPS JPY | Released Forecast Spread | -48,3 | -70,2 | 5,22 | -29,3 | -58,6 | -48,8 | -29,5 | -60,2 |
| Announcement Date | 14/05/21 | 13/05/22 | 12/08/22 | 10/02/23 | 15/05/23 | 14/08/23 | 09/02/24 | 13/05/24 |
| 01/07/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Kringle Pharma, Inc.
| 22/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 22/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 14/05/2024 05:00 pm | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 11:20 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4884 Stock
- Calendar Kringle Pharma, Inc.
